CD56 MicroBeads were developed for the positive selection or depletion of natural killer (NK) cells from human PBMCs or single-cell suspensions from tissues. The CD56 antigen is expressed by most NK cells and a minor T cell subset (CD3
+ CD56
+ NKT cells). Upon activation of NK cells, the surface expression of CD56 is increased.